Shire pharmaceuticals
Shire pharmaceuticals

One of our great hopes in recent years is that a Shire Pharmaceuticals programme, to develop a protein replacement therapy for a severe form of EB, will be a success. Unfortunately we have to report that Shire have hit a bump in the road.In the process of testing the therapy, they have received an indication that it might be toxic. We spoke with them to find out more and while this is a serious set-back, as of now, they remain committed to the programme. Please join with us in our earnest hope that this bump is surmountable and that the plans to develop this therapy for EB can continue. This article from our friends in DEBRA of America explains in more detail: http://bit.ly/shirepharma